TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2943640
log Bayes Factor = 15.9012
Chromosome 2   position 227,093,585  (GRCh37) Explore rs2943640 on Ensembl!
Variant rs2943640 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
E11.9 Without complications
0.000 0.000 1.000
I25 Chronic ischaemic heart disease
0.000 0.000 1.000
I25.9 Chronic ischaemic heart disease, unspecified
0.000 0.001 0.999
I25.8 Other forms of chronic ischaemic heart disease
0.000 0.003 0.997
I25.1 Atherosclerotic heart disease
0.000 0.030 0.970
I25.5 Ischaemic cardiomyopathy
0.000 0.039 0.961
I25.2 Old myocardial infarction
0.000 0.111 0.889
E11 Non-insulin-dependent diabetes mellitus
0.000 0.160 0.840
I25.0 Atherosclerotic cardiovascular disease, so described
0.000 0.163 0.837
E11.3 With ophthalmic complications
0.000 0.207 0.793
E10-E14 Diabetes mellitus
0.000 0.249 0.751
I20.9 Angina pectoris, unspecified
0.000 0.260 0.740
I20-I25 Ischaemic heart diseases
0.000 0.261 0.739
I20 Angina pectoris
0.000 0.266 0.734
E10 Insulin-dependent diabetes mellitus
0.000 0.269 0.731
E78.0 Pure hypercholesterolaemia
0.000 0.276 0.724
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.282 0.718
E10.1 With ketoacidosis
0.000 0.287 0.713
I25.6 Silent myocardial ischaemia
0.000 0.296 0.703
I25.3 Aneurysm of heart
0.000 0.319 0.681
E78.5 Hyperlipidaemia, unspecified
0.000 0.338 0.662
E78.2 Mixed hyperlipidaemia
0.000 0.353 0.647
E78.4 Other hyperlipidaemia
0.000 0.355 0.645
E10.5 With peripheral circulatory complications
0.000 0.364 0.636
E11.4 With neurological complications
0.000 0.365 0.635
E13 Other specified diabetes mellitus
0.000 0.366 0.634
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.378 0.622
E11.8 With unspecified complications
0.000 0.379 0.621
E78.1 Pure hyperglyceridaemia
0.000 0.390 0.610
E11.7 With multiple complications
0.000 0.398 0.602
E78.8 Other disorders of lipoprotein metabolism
0.000 0.401 0.599
E10.8 With unspecified complications
0.000 0.414 0.586
E10.9 Without complications
0.000 0.423 0.577
E13.9 Without complications
0.000 0.428 0.572
E10.0 With coma
0.000 0.431 0.569
E11.0 With coma
0.000 0.456 0.544
I20.0 Unstable angina
0.000 0.456 0.544
I22 Subsequent myocardial infarction
0.000 0.457 0.543
E11.6 With other specified complications
0.000 0.459 0.541
E12 Malnutrition-related diabetes mellitus
0.000 0.461 0.539
E10.7 With multiple complications
0.000 0.476 0.524
E78.3 Hyperchylomicronaemia
0.000 0.529 0.471
E10.6 With other specified complications
0.000 0.533 0.466
E13.8 With unspecified complications
0.000 0.545 0.455
E13.7 With multiple complications
0.000 0.545 0.455
E13.6 With other specified complications
0.000 0.545 0.455
E13.5 With peripheral circulatory complications
0.000 0.545 0.455
E13.4 With neurological complications
0.000 0.545 0.455
E13.2 With renal complications
0.000 0.545 0.455
E13.1 With ketoacidosis
0.000 0.545 0.455
E13.0 With coma
0.000 0.545 0.455
E10.3 With ophthalmic complications
0.000 0.556 0.444
E11.1 With ketoacidosis
0.000 0.556 0.443
E10.2 With renal complications
0.000 0.576 0.424
E11.5 With peripheral circulatory complications
0.000 0.582 0.418
E11.2 With renal complications
0.000 0.585 0.414
E78.6 Lipoprotein deficiency
0.000 0.591 0.409
I22.9 Subsequent myocardial infarction of unspecified site
0.000 0.596 0.404
E10.4 With neurological complications
0.000 0.597 0.403
I22.0 Subsequent myocardial infarction of anterior wall
0.000 0.600 0.400
E13.3 With ophthalmic complications
0.000 0.604 0.396
I23 Certain current complications following acute myocardial infarction
0.000 0.611 0.389
I25.4 Coronary artery aneurysm
0.001 0.612 0.387
E12.9 Without complications
0.000 0.614 0.386
E12.8 With unspecified complications
0.000 0.614 0.386
E12.7 With multiple complications
0.000 0.614 0.386
E12.6 With other specified complications
0.000 0.614 0.386
E12.5 With peripheral circulatory complications
0.000 0.614 0.386
E12.4 With neurological complications
0.000 0.614 0.386
E12.3 With ophthalmic complications
0.000 0.614 0.386
E12.2 With renal complications
0.000 0.614 0.386
E12.1 With ketoacidosis
0.000 0.614 0.386
E12.0 With coma
0.000 0.614 0.386
I22.1 Subsequent myocardial infarction of inferior wall
0.000 0.616 0.384
I22.8 Subsequent myocardial infarction of other sites
0.000 0.619 0.381
I20.8 Other forms of angina pectoris
0.000 0.631 0.369
E14 Unspecified diabetes mellitus
0.000 0.679 0.321
I20.1 Angina pectoris with documented spasm
0.000 0.696 0.304
I24 Other acute ischaemic heart diseases
0.000 0.702 0.298
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.000 0.721 0.279
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.000 0.721 0.279
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.000 0.721 0.279
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.000 0.721 0.279
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.000 0.721 0.279
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.000 0.721 0.279
E14.4 With neurological complications
0.000 0.755 0.245
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.001 0.757 0.242
I24.1 Dressler's syndrome
0.000 0.766 0.234
E14.7 With multiple complications
0.000 0.770 0.230
E14.5 With peripheral circulatory complications
0.000 0.770 0.230
E14.0 With coma
0.000 0.770 0.230
E14.9 Without complications
0.000 0.774 0.226
E14.2 Withrenal complications
0.000 0.774 0.226
E14.8 With unspecified complications
0.000 0.775 0.225
I24.8 Other forms of acute ischaemic heart disease
0.000 0.795 0.205
I23.8 Other current complications following acute myocardial infarction
0.001 0.799 0.201
E14.6 With other specified complications
0.000 0.804 0.196
E14.3 With ophthalmic complications
0.000 0.814 0.186
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.000 0.816 0.184
I21 Acute myocardial infarction
0.000 0.833 0.167
E14.1 With ketoacidosis
0.000 0.836 0.164
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.841 0.159
E70-E90 Metabolic disorders
0.000 0.842 0.158
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.857 0.142
T36-T50 Poisoning by drugs, medicaments and biological substances
0.140 0.860 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.139 0.861 0.000
I21.4 Acute subendocardial myocardial infarction
0.000 0.865 0.135
T42.4 Benzodiazepines
0.133 0.867 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.132 0.868 0.000
E85 Amyloidosis
0.000 0.869 0.131
E16 Other disorders of pancreatic internal secretion
0.000 0.869 0.131
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.130 0.870 0.000
E73 Lactose intolerance
0.000 0.871 0.129
T46 Poisoning by agents primarily affecting the cardiovascular system
0.128 0.872 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.126 0.874 0.000
E16.2 Hypoglycaemia, unspecified
0.000 0.876 0.124
I21.1 Acute transmural myocardial infarction of inferior wall
0.000 0.876 0.124
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.123 0.877 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.120 0.880 0.000
I21.X Presumed acute myicardial infaction (unconfirmed)
0.000 0.880 0.120
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.117 0.883 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.116 0.884 0.000
E77 Disorders of glycoprotein metabolism
0.000 0.886 0.114
E76 Disorders of glycosaminoglycan metabolism
0.000 0.886 0.114
E72 Other disorders of amino-acid metabolism
0.000 0.886 0.114
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.886 0.114
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.886 0.114
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.887 0.113
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.113 0.887 0.000
I21.2 Acute transmural myocardial infarction of other sites
0.000 0.888 0.112
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.112 0.888 0.000
E79 Disorders of purine and pyrimidine metabolism
0.000 0.888 0.112
T42.0 Hydantoin derivatives
0.111 0.889 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.110 0.890 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.108 0.892 0.000
E85.4 Organ-limited amyloidosis
0.000 0.892 0.108
I60 Subarachnoid haemorrhage
0.000 0.892 0.108
E73.9 Lactose intolerance, unspecified
0.000 0.893 0.107
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.107 0.893 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.106 0.894 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.106 0.894 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.105 0.894 0.000
E70 Disorders of aromatic amino-acid metabolism
0.000 0.895 0.105
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.104 0.896 0.000
I60.9 Subarachnoid haemorrhage, unspecified
0.000 0.896 0.104
T40.6 Other and unspecified narcotics
0.103 0.897 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.103 0.897 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.897 0.103
E15 Nondiabetic hypoglycaemic coma
0.000 0.898 0.102
T46.1 Calcium-channel blockers
0.102 0.898 0.000
E85.9 Amyloidosis, unspecified
0.000 0.898 0.102
T38.1 Thyroid hormones and substitutes
0.102 0.898 0.000
T42.3 Barbiturates
0.101 0.899 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.101 0.899 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.101 0.899 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.101 0.899 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.099 0.900 0.000
T42.2 Succinimides and oxazolidinediones
0.099 0.900 0.000
T40.2 Other opioids
0.098 0.902 0.000
E85.3 Secondary systemic amyloidosis
0.000 0.902 0.098
T43.5 Other and unspecified antipsychotics and neuroleptics
0.098 0.902 0.000
E84 Cystic fibrosis
0.000 0.902 0.097
I60.2 Subarachnoid haemorrhage from anterior communicating artery
0.000 0.903 0.097
T43.4 Butyrophenone and thioxanthene neuroleptics
0.096 0.904 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.905 0.095
I60-I69 Cerebrovascular diseases
0.000 0.905 0.095
E74 Other disorders of carbohydrate metabolism
0.000 0.905 0.095
T47.0 Histamine H(2)-receptor antagonists
0.095 0.905 0.000
T38.9 Other and unspecified hormone antagonists
0.095 0.905 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.095 0.905 0.000
T38.7 Androgens and anabolic congeners
0.095 0.905 0.000
T38.5 Other oestrogens and progestogens
0.095 0.905 0.000
T38.4 Oral contraceptives
0.095 0.905 0.000
T38.2 Antithyroid drugs
0.095 0.905 0.000
T38.0 Glucocorticoids and synthetic analogues
0.095 0.905 0.000
Chapter IX Diseases of the circulatory system
0.000 0.905 0.095
T46.5 Other antihypertensive drugs, not elsewhere classified
0.094 0.906 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.906 0.094
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.906 0.094
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.906 0.094
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.906 0.094
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.906 0.094
E16.4 Abnormal secretion of gastrin
0.000 0.906 0.094
E16.3 Increased secretion of glucagon
0.000 0.906 0.094
I60.1 Subarachnoid haemorrhage from middle cerebral artery
0.000 0.906 0.094
T50.7 Analeptics and opioid receptor antagonists
0.093 0.907 0.000
T50.5 Appetite depressants
0.093 0.907 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.093 0.907 0.000
T50.1 Loop [high-ceiling] diuretics
0.093 0.907 0.000
T50.0 Mineralocorticoids and their antagonists
0.093 0.907 0.000
T43.6 Psychostimulants with abuse potential
0.093 0.907 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.093 0.907 0.000
E73.8 Other lactose intolerance
0.000 0.907 0.092
E73.1 Secondary lactase deficiency
0.000 0.907 0.092
E73.0 Congenital lactase deficiency
0.000 0.907 0.092
I60.3 Subarachnoid haemorrhage from posterior communicating artery
0.000 0.908 0.092
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.092 0.908 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.092 0.908 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.092 0.908 0.000
T46.7 Peripheral vasodilators
0.092 0.908 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.092 0.908 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.092 0.908 0.000
T36 Poisoning by systemic antibiotics
0.092 0.908 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.091 0.909 0.000
T47.4 Other laxatives
0.090 0.910 0.000
T50.4 Drugs affecting uric acid metabolism
0.090 0.910 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.088 0.912 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.088 0.912 0.000
T47.7 Emetics
0.088 0.912 0.000
T47.6 Antidiarrhoeal drugs
0.088 0.912 0.000
T47.5 Digestants
0.088 0.912 0.000
T47.3 Saline and osmotic laxatives
0.088 0.912 0.000
T47.2 Stimulant laxatives
0.088 0.912 0.000
I21.3 Acute transmural myocardial infarction of unspecified site
0.000 0.912 0.088
T50.8 Diagnostic agents
0.087 0.913 0.000
T43.9 Psychotropic drug, unspecified
0.086 0.913 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.086 0.913 0.000
I61 Intracerebral haemorrhage
0.000 0.914 0.086
E88 Other metabolic disorders
0.000 0.915 0.085
E85.8 Other amyloidosis
0.000 0.916 0.084
I60.6 Subarachnoid haemorrhage from other intracranial arteries
0.000 0.916 0.084
E80.2 Other porphyria
0.000 0.916 0.084
T50.6 Antidotes and chelating agents, not elsewhere classified
0.084 0.916 0.000
T42.1 Iminostilbenes
0.084 0.916 0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation
0.000 0.916 0.084
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.083 0.916 0.000
T40.8 Lysergide [LSD]
0.083 0.916 0.000
T40.7 Cannabis (derivatives)
0.083 0.916 0.000
T40.3 Methadone
0.083 0.916 0.000
T40.0 Opium
0.083 0.916 0.000
E16.1 Other hypoglycaemia
0.000 0.917 0.083
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.083 0.917 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.082 0.918 0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified
0.000 0.918 0.082
E71.3 Disorders of fatty-acid metabolism
0.000 0.918 0.082
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.918 0.082
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.918 0.082
E71.0 Maple-syrup-urine disease
0.000 0.918 0.082
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.918 0.082
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.918 0.082
E72.5 Disorders of glycine metabolism
0.000 0.918 0.082
E72.4 Disorders of ornithine metabolism
0.000 0.918 0.082
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.918 0.082
E72.2 Disorders of urea cycle metabolism
0.000 0.918 0.082
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.918 0.082
E72.0 Disorders of amino-acid transport
0.000 0.918 0.082
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.918 0.082
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.918 0.082
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.918 0.082
E76.2 Other mucopolysaccharidoses
0.000 0.918 0.082
E76.1 Mucopolysaccharidosis, type II
0.000 0.918 0.082
E76.0 Mucopolysaccharidosis, type I
0.000 0.918 0.082
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.918 0.082
E77.8 Other disorders of glycoprotein metabolism
0.000 0.918 0.082
E77.1 Defects in glycoprotein degradation
0.000 0.918 0.082
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.918 0.082
T40.1 Heroin
0.082 0.918 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.081 0.918 0.000
E80.6 Other disorders of bilirubin metabolism
0.000 0.918 0.081
E75.6 Lipid storage disorder, unspecified
0.000 0.919 0.081
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.919 0.081
E75.3 Sphingolipidosis, unspecified
0.000 0.919 0.081
E75.2 Other sphingolipidosis
0.000 0.919 0.081
E75.1 Other gangliosidosis
0.000 0.919 0.081
E75.0 GM2 gangliosidosis
0.000 0.919 0.081
T40.5 Cocaine
0.081 0.919 0.000
E75.5 Other lipid storage disorders
0.000 0.919 0.081
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.081 0.919 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.919 0.080
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.919 0.080
E79.1 Lesch-Nyhan syndrome
0.000 0.919 0.080
T43.2 Other and unspecified antidepressants
0.080 0.920 0.000
I10-I15 Hypertensive diseases
0.000 0.921 0.079
I61.1 Intracerebral haemorrhage in hemisphere, cortical
0.000 0.921 0.079
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.921 0.079
I62 Other nontraumatic intracranial haemorrhage
0.000 0.921 0.079
I10 Essential (primary) hypertension
0.000 0.922 0.078
I61.9 Intracerebral haemorrhage, unspecified
0.000 0.922 0.078
I67 Other cerebrovascular diseases
0.000 0.922 0.078
I67.1 Cerebral aneurysm, nonruptured
0.000 0.922 0.078
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.078 0.922 0.000
I60.5 Subarachnoid haemorrhage from vertebral artery
0.000 0.922 0.077
I05-I09 Chronic rheumatic heart diseases
0.000 0.923 0.077
I60.8 Other subarachnoid haemorrhage
0.000 0.923 0.077
E40-E46 Malnutrition
0.001 0.923 0.076
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.076 0.924 0.000
T37.5 Antiviral drugs
0.076 0.924 0.000
T37.4 Anthelminthics
0.076 0.924 0.000
T37.3 Other antiprotozoal drugs
0.076 0.924 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.076 0.924 0.000
T37.1 Antimycobacterial drugs
0.076 0.924 0.000
T37.0 Sulphonamides
0.076 0.924 0.000
T49.9 Topical agent, unspecified
0.076 0.924 0.000
T49.8 Other topical agents
0.076 0.924 0.000
T49.7 Dental drugs, topically applied
0.076 0.924 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.076 0.924 0.000
T49.5 Ophthalmological drugs and preparations
0.076 0.924 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.076 0.924 0.000
T49.3 Emollients, demulcents and protectants
0.076 0.924 0.000
T49.2 Local astringents and local detergents
0.076 0.924 0.000
T49.1 Antipruritics
0.076 0.924 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.076 0.924 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.924 0.075
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.924 0.075
E70.2 Disorders of tyrosine metabolism
0.000 0.924 0.075
E70.1 Other hyperphenylalaninaemias
0.000 0.924 0.075
E70.0 Classical phenylketonuria
0.000 0.924 0.075
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.075 0.925 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.075 0.925 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.075 0.925 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.075 0.925 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.075 0.925 0.000
T44.0 Anticholinesterase agents
0.075 0.925 0.000
I61.3 Intracerebral haemorrhage in brain stem
0.000 0.925 0.075
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.926 0.074
E80.5 Crigler-Najjar syndrome
0.000 0.926 0.074
E80.3 Defects of catalase and peroxydase
0.000 0.926 0.074
E80.0 Hereditary erythropoietic porphyria
0.000 0.926 0.074
I05 Rheumatic mitral valve diseases
0.000 0.926 0.074
T41.5 Therapeutic gases
0.072 0.927 0.000
T41.4 Anaesthetic, unspecified
0.072 0.927 0.000
T41.3 Local anaesthetics
0.072 0.927 0.000
T41.2 Other and unspecified general anaesthetics
0.072 0.927 0.000
T41.1 Intravenous anaesthetics
0.072 0.927 0.000
T41.0 Inhaled anaesthetics
0.072 0.927 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.072 0.927 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.072 0.927 0.000
T48.5 Anti-common-cold drugs
0.072 0.927 0.000
T48.4 Expectorants
0.072 0.927 0.000
T48.3 Antitussives
0.072 0.927 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.072 0.927 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.072 0.927 0.000
T48.0 Oxytocic drugs
0.072 0.927 0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)
0.000 0.928 0.072
I68 Cerebrovascular disorders in diseases classified elsewhere
0.000 0.928 0.071
E80.1 Porphyria cutanea tarda
0.000 0.929 0.071
E84.8 Cystic fibrosis with other manifestations
0.000 0.930 0.070
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.930 0.070
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.930 0.070
I05.2 Mitral stenosis with insufficiency
0.000 0.930 0.070
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.932 0.068
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.932 0.068
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.932 0.068
E74.2 Disorders of galactose metabolism
0.000 0.932 0.068
E74.1 Disorders of fructose metabolism
0.000 0.932 0.068
E74.0 Glycogen storage disease
0.000 0.932 0.068
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction
0.000 0.932 0.067
T36.4 Tetracyclines
0.067 0.933 0.000
E70.3 Albinism
0.000 0.933 0.067
T36.9 Systemic antibiotic, unspecified
0.066 0.934 0.000
T36.8 Other systemic antibiotics
0.066 0.934 0.000
T36.7 Antifungal antibiotics, systemically used
0.066 0.934 0.000
T36.6 Rifamycins
0.066 0.934 0.000
T36.5 Aminoglycosides
0.066 0.934 0.000
T36.3 Macrolides
0.066 0.934 0.000
T36.2 Chloramphenicol group
0.066 0.934 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.066 0.934 0.000
I60.4 Subarachnoid haemorrhage from basilar artery
0.000 0.934 0.066
I00-I02 Acute rheumatic fever
0.000 0.935 0.065
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.065 0.935 0.000
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.936 0.064
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.937 0.063
T45.0 Antiallergic and antiemetic drugs
0.062 0.938 0.000
I67.2 Cerebral atherosclerosis
0.000 0.938 0.062
E88.9 Metabolic disorder, unspecified
0.000 0.939 0.061
E50-E64 Other nutritional deficiencies
0.000 0.939 0.061
T45.9 Primarily systemic and haematological agent, unspecified
0.060 0.940 0.000
T45.8 Other primarily systemic and haematological agents
0.060 0.940 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.060 0.940 0.000
T45.6 Fibrinolysis-affecting drugs
0.060 0.940 0.000
T45.4 Iron and its compounds
0.060 0.940 0.000
T45.3 Enzymes, not elsewhere classified
0.060 0.940 0.000
I05.9 Mitral valve disease, unspecified
0.000 0.941 0.059
I67.0 Dissection of cerebral arteries, nonruptured
0.000 0.942 0.058
T45.1 Antineoplastic and immunosuppressive drugs
0.058 0.942 0.000
E88.3 Tumour lysis syndrome
0.000 0.942 0.057
T45.2 Vitamins, not elsewhere classified
0.057 0.943 0.000
I13 Hypertensive heart and renal disease
0.000 0.943 0.057
I61.2 Intracerebral haemorrhage in hemisphere, unspecified
0.000 0.943 0.057
E88.2 Lipomatosis, not elsewhere classified
0.000 0.944 0.056
I67.7 Cerebral arteritis, not elsewhere classified
0.000 0.944 0.056
I67.6 Nonpyogenic thrombosis of intracranial venous system
0.000 0.944 0.056
I67.5 Moyamoya disease
0.000 0.944 0.056
I67.4 Hypertensive encephalopathy
0.000 0.944 0.056
I67.3 Progressive vascular leukoencephalopathy
0.000 0.944 0.056
T36.0 Penicillins
0.056 0.944 0.000
I61.4 Intracerebral haemorrhage in cerebellum
0.000 0.944 0.056
I62.1 Nontraumatic extradural haemorrhage
0.000 0.944 0.056
E44 Protein-energy malnutrition of moderate and mild degree
0.001 0.945 0.055
E45 Retarded development following protein-energy malnutrition
0.001 0.945 0.055
E43 Unspecified severe protein-energy malnutrition
0.001 0.945 0.055
E42 Marasmic kwashiorkor
0.001 0.945 0.055
E41 Nutritional marasmus
0.001 0.945 0.055
E40 Kwashiorkor
0.001 0.945 0.055
I05.1 Rheumatic mitral insufficiency
0.000 0.945 0.055
I68.0 Cerebral amyloid angiopathy
0.000 0.945 0.055
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.945 0.055
I09 Other rheumatic heart diseases
0.000 0.946 0.054
I07 Rheumatic tricuspid valve diseases
0.000 0.946 0.054
E84.9 Cystic fibrosis, unspecified
0.000 0.946 0.054
I61.6 Intracerebral haemorrhage, multiple localised
0.000 0.946 0.054
I61.0 Intracerebral haemorrhage in hemisphere, subcortical
0.000 0.947 0.053
I05.8 Other mitral valve diseases
0.000 0.947 0.053
I05.0 Mitral stenosis
0.000 0.947 0.053
E88.8 Other specified metabolic disorders
0.000 0.948 0.052
I61.5 Intracerebral haemorrhage, intraventricular
0.000 0.948 0.052
I68.8 Other cerebrovascular disorders in diseases classified elsewhere
0.000 0.948 0.051
I68.2 Cerebral arteritis in other diseases classified elsewhere
0.000 0.948 0.051
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere
0.000 0.948 0.051
T43.3 Phenothiazine antipsychotics and neuroleptics
0.051 0.949 0.000
I21.9 Acute myocardial infarction, unspecified
0.000 0.949 0.051
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.950 0.050
I66.3 Occlusion and stenosis of cerebellar arteries
0.000 0.950 0.050
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.950 0.049
I61.8 Other intracerebral haemorrhage
0.000 0.951 0.049
I66.9 Occlusion and stenosis of unspecified cerebral artery
0.000 0.951 0.049
I66.8 Occlusion and stenosis of other cerebral artery
0.000 0.951 0.048
I66.2 Occlusion and stenosis of posterior cerebral artery
0.000 0.951 0.048
I66.1 Occlusion and stenosis of anterior cerebral artery
0.000 0.951 0.048
E65-E68 Obesity and other hyperalimentation
0.000 0.951 0.048
I66.0 Occlusion and stenosis of middle cerebral artery
0.000 0.952 0.048
T40.4 Other synthetic narcotics
0.047 0.953 0.000
I02 Rheumatic chorea
0.000 0.953 0.047
I01 Rheumatic fever with heart involvement
0.000 0.953 0.047
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries
0.000 0.953 0.046
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction
0.000 0.953 0.047
E89.2 Postprocedural hypoparathyroidism
0.000 0.954 0.046
T45.5 Anticoagulants
0.046 0.954 0.000
I62.9 Intracranial haemorrhage (nontraumatic), unspecified
0.000 0.954 0.045
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.955 0.045
E89.1 Postprocedural hypoinsulinaemia
0.000 0.955 0.045
I00 Rheumatic fever without mention of heart involvement
0.000 0.956 0.044
I15 Secondary hypertension
0.000 0.956 0.044
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.956 0.044
E63 Other nutritional deficiencies
0.000 0.956 0.044
E50 Vitamin A deficiency
0.000 0.956 0.044
E60 Dietary zinc deficiency
0.000 0.956 0.044
E59 Dietary selenium deficiency
0.000 0.956 0.044
E52 Niacin deficiency [pellagra]
0.000 0.956 0.044
E58 Dietary calcium deficiency
0.000 0.956 0.044
E56 Other vitamin deficiencies
0.000 0.956 0.044
I70-I79 Diseases of arteries, arterioles and capillaries
0.000 0.956 0.044
E51 Thiamine deficiency
0.000 0.958 0.042
I69 Sequelae of cerebrovascular disease
0.000 0.958 0.042
I12 Hypertensive renal disease
0.000 0.958 0.042
I06 Rheumatic aortic valve diseases
0.000 0.958 0.041
I78 Diseases of capillaries
0.000 0.959 0.041
E89.4 Postprocedural ovarian failure
0.000 0.959 0.041
I11 Hypertensive heart disease
0.000 0.959 0.041
I13.9 Hypertensive heart and renal disease, unspecified
0.000 0.959 0.041
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure
0.000 0.959 0.041
I13.1 Hypertensive heart and renal disease with renal failure
0.000 0.959 0.041
I13.0 Hypertensive heart and renal disease with (congestive) heart failure
0.000 0.959 0.041
E89.0 Postprocedural hypothyroidism
0.000 0.959 0.041
E61 Deficiency of other nutrient elements
0.000 0.959 0.041
E89.5 Postprocedural testicular hypofunction
0.000 0.959 0.041
E44.1 Mild protein-energy malnutrition
0.001 0.960 0.039
E44.0 Moderate protein-energy malnutrition
0.001 0.960 0.039
I09.8 Other specified rheumatic heart diseases
0.000 0.961 0.039
I09.2 Chronic rheumatic pericarditis
0.000 0.961 0.039
I09.1 Rheumatic diseases of endocardium, valve unspecified
0.000 0.961 0.039
I09.0 Rheumatic myocarditis
0.000 0.961 0.039
I07.9 Tricuspid valve disease, unspecified
0.000 0.961 0.039
I07.8 Other tricuspid valve diseases
0.000 0.961 0.039
I07.2 Tricuspid stenosis with insufficiency
0.000 0.961 0.039
I07.0 Tricuspid stenosis
0.000 0.961 0.039
I08 Multiple valve diseases
0.000 0.961 0.039
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.962 0.038
I09.9 Rheumatic heart disease, unspecified
0.000 0.962 0.038
I69.1 Sequelae of intracerebral haemorrhage
0.000 0.962 0.038
I07.1 Tricuspid insufficiency
0.000 0.962 0.038
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries
0.000 0.963 0.037
I08.8 Other multiple valve diseases
0.000 0.963 0.037
E55 Vitamin D deficiency
0.000 0.963 0.037
I78.0 Hereditary haemorrhagic telangiectasia
0.000 0.963 0.037
E53 Deficiency of other B group vitamins
0.000 0.963 0.037
E54 Ascorbic acid deficiency
0.000 0.963 0.036
I78.1 Naevus, nonneoplastic
0.000 0.964 0.036
I74 Arterial embolism and thrombosis
0.000 0.964 0.036
I65.0 Occlusion and stenosis of vertebral artery
0.000 0.965 0.035
E67 Other hyperalimentation
0.000 0.965 0.035
E68 Sequelae of hyperalimentation
0.000 0.965 0.035
I01.9 Acute rheumatic heart disease, unspecified
0.000 0.966 0.034
I01.8 Other acute rheumatic heart disease
0.000 0.966 0.034
I01.2 Acute rheumatic myocarditis
0.000 0.966 0.034
I01.1 Acute rheumatic endocarditis
0.000 0.966 0.034
I01.0 Acute rheumatic pericarditis
0.000 0.966 0.034
I02.9 Rheumatic chorea without heart involvement
0.000 0.966 0.034
I02.0 Rheumatic chorea with heart involvement
0.000 0.966 0.034
I65.9 Occlusion and stenosis of unspecified precerebral artery
0.000 0.966 0.034
I74.8 Embolism and thrombosis of other arteries
0.000 0.967 0.033
I74.5 Embolism and thrombosis of iliac artery
0.000 0.967 0.033
I15.8 Other secondary hypertension
0.000 0.968 0.032
I15.2 Hypertension secondary to endocrine disorders
0.000 0.968 0.032
E50.9 Vitamin A deficiency, unspecified
0.000 0.968 0.032
E50.8 Other manifestations of vitamin A deficiency
0.000 0.968 0.032
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.968 0.032
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.968 0.032
E50.5 Vitamin A deficiency with night blindness
0.000 0.968 0.032
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.968 0.032

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.